Melissa J. Contos

24.6k citations

58 papers · 18.5k indexed · 10 hit papers · h-index 36

Epidemiology top 0.02%
Hepatology top 0.05%
Endocrinology, Diabetes and Metabolism top 0.05%
Molecular Biology top 2%
Surgery top 0.5%

Co-authors: Arun J. Sanyal David E. Kleiner Cynthia Behling Oscar W. Cummings Elizabeth M. Brunt Matthew M. Yeh Linda D. Ferrell Arthur J. McCullough
Topics: Liver Disease Diagnosis and Treatment (45 papers)Hepatitis C virus research (24 papers)Liver Disease and Transplantation (12 papers)
Cited by: Hepatology Epidemiology Endocrinology, Diabetes and Metabolism
Journals: Gastroenterology Hepatology Cell Metabolism
Partner nations: United States China Denmark

In The Last Decade

Melissa J. Contos

58 papers receiving 18.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

2005 8.4k citations David E. Kleiner, Elizabeth M. Brunt et al. Hepatology profile →
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

2001 1.7k citations Arun J. Sanyal, Faridoddin Mirshahi et al. profile →
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

2009 1.1k citations Melissa J. Contos, Arun J. Sanyal et al. Clinical Gastroenterology and Hepatology profile →
A lipidomic analysis of nonalcoholic fatty liver disease

2007 1.1k citations Prem Puri, Rebecca Baillie et al. Hepatology profile →
Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values

2003 909 citations Melissa J. Contos, Carol Sargeant et al. Hepatology profile →
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

2008 557 citations Onpan Cheung, Prem Puri et al. Hepatology profile →
The plasma lipidomic signature of nonalcoholic steatohepatitis†‡

2009 521 citations Prem Puri, Michelle M. Wiest et al. Hepatology profile →
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

2012 517 citations Hae‐Ki Min, Michael Fuchs et al. profile →
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

2017 325 citations Prem Puri, Kalyani Daita et al. Hepatology profile →
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

2019 270 citations David E. Kleiner, Elizabeth M. Brunt et al. profile →

Peers

Countries citing papers authored by Melissa J. Contos

Since Specialization

Citations

This map shows the geographic impact of Melissa J. Contos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa J. Contos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa J. Contos more than expected).

Fields of papers citing papers by Melissa J. Contos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa J. Contos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa J. Contos. The network helps show where Melissa J. Contos may publish in the future.

Co-authorship network of co-authors of Melissa J. Contos

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa J. Contos. A scholar is included among the top collaborators of Melissa J. Contos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa J. Contos. Melissa J. Contos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease 2019 ·Scientific Reports ·Stephen A. Hoang,Abdul M. Oseini,Ryan E. Feaver,Banumathi K. Cole,Amon Asgharpour,Robert Vincent,Mohammad Shadab Siddiqui,Mark Lawson,(unknown),Justin Taylor,Brian R. Wamhoff,Faridoddin Mirshahi,Melissa J. Contos,Michael O. Idowu,Arun J. Sanyal	100
2	The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acidsbreakdown → 2017 ·Hepatology ·Prem Puri,Kalyani Daita,Andrew Joyce,Faridoddin Mirshahi,Prasanna K. Santhekadur,Sophie C. Cazanave,Velimir A. Luketic,Mohammad Shadab Siddiqui,Sherry Boyett,Hae‐Ki Min,Divya P. Kumar,Rohit Kohli,Huiping Zhou,Phillip B. Hylemon,Melissa J. Contos,Michael O. Idowu,Arun J. Sanyal	325
3	Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile 2014 ·Clinical Gastroenterology and Hepatology ·Mohammad Shadab Siddiqui,Michael Fuchs,Michael O. Idowu,Velimir A. Luketic,Sherry Boyett,Carol Sargeant,Richard T. Stravitz,Prem Puri,Scott Matherly,Richard K. Sterling,Melissa J. Contos,Arun J. Sanyal	174
4	Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionbreakdown → 2008 ·Hepatology ·Onpan Cheung,Prem Puri,Christoph Eicken,Melissa J. Contos,Faridoddin Mirshahi,James W. Maher,John M. Kellum,Hae‐Ki Min,Velimir A. Luketic,Arun J. Sanyal	557
5	A lipidomic analysis of nonalcoholic fatty liver diseasebreakdown → 2007 ·Hepatology ·Prem Puri,Rebecca Baillie,Michelle M. Wiest,Faridoddin Mirshahi,Jayanta Choudhury,Onpan Cheung,Carol Sargeant,Melissa J. Contos,Arun J. Sanyal	1056
6	A Prospective Evaluation of Fibrosis Progression in Patients with Recurrent Hepatitis C Virus Following Liver Transplantation† 2007 ·Liver Transplantation ·Nevin Yılmaz,Mitchell L. Shiffman,R. Todd Stravitz,Richard K. Sterling,Velimir A. Luketic,Arun J. Sanyal,A. Scott Mills,Melissa J. Contos,(unknown),Daniel G. Maluf,Marc P. Posner,Robert A. Fisher	101
7	Design and validation of a histological scoring system for nonalcoholic fatty liver disease†breakdown → 2005 ·Hepatology ·David E. Kleiner,Elizabeth M. Brunt,Mark L. Van Natta,Cynthia Behling,Melissa J. Contos,Oscar W. Cummings,Linda D. Ferrell,Yao‐Chang Liu,Michael Torbenson,Aynur Ünalp–Arida,Matthew M. Yeh,Arthur J. McCullough,Arun J. Sanyal	8351
8	The Spectrum of Chronic Hepatitis C Virus Infection in the Virginia Correctional System: Development of a Strategy for the Evaluation and Treatment of Inmates with HCV 2005 ·The American Journal of Gastroenterology ·Richard K. Sterling,Robert S. Brown,Charlotte M. Hofmann,Velimir A. Luketic,R. Todd Stravitz,Arun J. Sanyal,Melissa J. Contos,A. Scott Mills,Vernon M. Smith,Mitchell L. Shiffman	10
9	Four‐year follow‐up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation 2004 ·Clinical Transplantation ·Robert A. Fisher,(unknown),Luke G. Wolfe,(unknown),(unknown),Richard K. Sterling,Mitchell L. Shiffman,(unknown),Melissa J. Contos,A. Scott Mills,Andrea Ferreira‐Gonzalez,Marc P. Posner	47
10	The histologic spectrum of nonalcoholic fatty liver disease 2004 ·Clinics in Liver Disease ·Melissa J. Contos,Jayanta Choudhury,A. Scott Mills,Arun J. Sanyal	56
11	The Clinical Spectrum of Hepatitis C Virus in HIV Coinfection 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Richard K. Sterling,Melissa J. Contos,Arun J. Sanyal,Velimir A. Luketic,R. Todd Stravitz,Mary Sweig Wilson,A. Scott Mills,Mitchell L. Shiffman	37
12	Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Valuesbreakdown → 2003 ·Hepatology ·(unknown),Melissa J. Contos,(unknown),Carol Sargeant,Robert A. Fisher,Velimir A. Luketic,Richard K. Sterling,Mitchell L. Shiffman,Richard T. Stravitz,Arun J. Sanyal	909
13	Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome 2003 ·The American Journal of Gastroenterology ·Arun J. Sanyal,Melissa J. Contos,Richard K. Sterling,Velimir A. Luketic,Mitchell L. Shiffman,R. Todd Stravitz,A. Scott Mills	135
14	Non-Resective Ablation and Liver Transplantation in Patients with Cirrhosis and Hepatocellular Carcinoma (HCC): Safety and Efficacy 2003 ·American Journal of Transplantation ·Daniel G. Maluf,Robert A. Fisher,Timothy P. Maroney,Adrian Cotterell,Ann S. Fulcher,Jaime Tisnado,Melissa J. Contos,Velimir A. Luketic,R. Todd Stravitz,Mitchell L. Shiffman,Richard K. Sterling,(unknown)	35
15	Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis 2001 ·Liver Transplantation ·Melissa J. Contos,(unknown),Richard K. Sterling,Velimir A. Luketic,Mitchell L. Shiffman,A. Scott Mills,Robert A. Fisher,J. M. Ham,Arun J. Sanyal	290
16	A Randomized, Controlled Trial to Determine Whether Continued Ribavirin Monotherapy in Hepatitis C Virus–Infected Patients Who Responded to Interferon‐Ribavirin Combination Therapy Will Enhance Sustained Virologic Response 2001 ·The Journal of Infectious Diseases ·Mitchell L. Shiffman,Charlotte M. Hofmann,Richard K. Sterling,Velimir A. Luketic,Melissa J. Contos,Arun J. Sanyal	25
17	Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: Characterization of cell phenotype and function 1998 ·Hepatology ·Arun J. Sanyal,Melissa J. Contos,(unknown),Yanan Zhu,Amy Willey,Martin F. Graham	38
18	Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C 1997 ·Hepatology ·Mitchell L. Shiffman,Charlotte M. Hofmann,Elizabeth Thompson,Andrea Ferreira‐Gonzalez,Melissa J. Contos,Abraham Koshy,Velimir A. Luketic,Arun J. Sanyal,A. Scott Mills,Carleton T. Garrett	134
19	Improved Sustained Response Following Treatment of Chronic Hepatitis C by Gradual Reduction in the Interferon Dose 1996 ·Hepatology ·Mitchell L. Shiffman,Charlotte M. Hofmann,(unknown),Arun J. Sanyal,Melissa J. Contos,A. Scott Mills	31
20	Malignant lymphoma can present as hepatobiliary disease 1996 ·Cancer ·(unknown),Jonathan Ben‐Ezra,Melissa J. Contos,Michael J. Kornstein	22

About Melissa J. Contos

Melissa J. Contos is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 58 papers that have together received 18.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (45 papers), Hepatitis C virus research (24 papers) and Liver Disease and Transplantation (12 papers). The work is most often cited by research in Hepatology (7.3k citations), Epidemiology (15.9k citations) and Endocrinology, Diabetes and Metabolism (6.0k citations). Melissa J. Contos has collaborated with scholars based in United States, China and Denmark. Frequent co-authors include Arun J. Sanyal, David E. Kleiner, Cynthia Behling, Oscar W. Cummings, Elizabeth M. Brunt, Matthew M. Yeh, Linda D. Ferrell, Arthur J. McCullough, Mark L. Van Natta and Aynur Ünalp–Arida. Their work appears in journals such as Gastroenterology, Hepatology and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact